Steering Committee

Melissa Culligan is a Clinical Instructor in Surgery at the University of Maryland School of Medicine and the Director of Clinical Research for the Division of Thoracic Surgery at the University of Maryland Medical Center.  She serves on the International Society of the Study of Lung Cancer (IASLC) Nursing and Allied Health Committee and the IASLC Continuing Medical Education Committee and as a former Chair for the International Thoracic Oncology Nursing Forum. She received her undergraduate degree from Wilkes University and went on to receive a Masters of Science degree from Drexel University College of Medicine in area of Clinical Research. She has more than 30 years of experience working in the field of thoracic surgery with a special focus and expertise in caring for patients with malignant pleural mesothelioma and advanced stage lung cancer.  She is the co-author of multiple peer-reviewed papers on the topics of lung cancer and mesothelioma and has lectured nationally and internationally on the nursing care of patients undergoing thoracic surgery. She has a special interest in clinical trial development and management for thoracic oncology patients and leads multiple surgery-based clinical trials at the University of Maryland Medical Center. She is currently a PhD candidate at the University of Maryland School of Nursing. Her doctoral research is focused on the standardization of and outcomes measurements for patients undergoing lung-sparing surgery for malignant pleural mesothelioma.

Maria has worked in respiratory medicine at University hospital Aintree, UK since qualifying in 1989.

She became one on the first Lung Cancer Clinical nurse specialist (CNS) in the North West in 1997.

Along with a colleague in the Manchester area, Maria co-founded the North West lung cancer nurses group, with the aim of support, education and development in 1997. This was thought to be the first such group in the UK of its kind at the time and subsequently led to the formation of the National Lung Cancer Forum for Nurses.(NLCFN) Maria was involved in the inaugural setting up and recruitment to the Roy Castle support group, Liverpool in 1991/2000.

Maria was NLCFN committee member for 9 years and completed her term of office as chair of 3 years in 2008.

During her time as chairperson she was a keen advocate of true Multidisciplinary team (MDT) working, including highlighting the importance and  protecting the role of the Lung CNS .In collaboration with the  United Kingdom Lung Cancer Coalition(UKLCC)conducted the NLCFN first parliamentary “fly in” accentuating the importance of specialist nurse support for all patients with Lung cancer.

Maria has been involved in many of the NLCFN projects highlighting CNS influence in improving patient and carer experience across the whole cancer pathway.

Maria is a member of the NLCFN Research Interest Group (RIG) and has contributed to many of the research projects over the past decade. Maria has published papers on various clinical topics including developmental roles in cancer services and management of patients receiving oral therapies

Maria has presented at conferences both nationally and internationally on nursing topics such as management of toxicity/Holistic needs Assessment /Patient reported outcomes and cancer survivorship initiatives.

Maria continues to represent lung cancer nurses on various committees/advisory bodies both locally and nationally. Since 2010 Maria has represented the UK on the International Thoracic Oncology Nurses Forum, (ITONF) and is the current chair.

Maria was an inaugural member of the MNAT (Mesothelioma Nurse Action Team) representing the network and has been Meso UK Clinical nurse specialist since January this year.

Beth Ivimey is a passionate oncology nurse who has specialised in thoracic oncology. Beth is a proud founding member & was the inaugural Chair of ITONF & is the Co Chair of ANZ-LCNF. Beth serves on national & international oncology nurse & thoracic oncology related committees. Beth has represented thoracic oncology nursing writing policy in the Management of Lung Cancer & the first Australian Guidelines on the Management of Pleural Mesothelioma. Beth has been an invited speaker at national & international Oncology Nurse & Thoracic Oncology conferences.

Beth currently works at Bankstown Hospital as Nurse Coordinator for Thoracic Oncology patients &  at Liverpool Hospital as Survivorship Nurse. Beth continues to share her passion for Thoracic Oncology Education & updates at any given opportunity & frequently organises Thoracic Oncology Education for Nurses & Allied Health Professionals in collaboration with Lung Foundation Australia.

Caitlin, RN, has completed her Masters of Oncology-NP, and is currently working in Medical Oncology at Royal Perth Hospital as a Nurse Practitioner, For 12 years previously she was working as a Thoracic Cancer Nurse Consultant at The Western Australian Cancer and Palliative Care Network, in Perth, WA.

Caitlin has been a past committee member of The Australian and New Zealand Lung Cancer Forum (ANZLCNF), The Australian Lung Cancer Group (ALCG), a member of The Australian Lung Trials Group and has been a committee member of the International Thoracic Oncology Nursing Forum (ITONF) since 2010, currently vice chair.

Caitlin has a passion for improving the care and outcomes of lung cancer patients,. Furthering her own education and knowledge has been a constant in her career, and sharing this with others is something that she is committed to, ultimately improving the pathway for thoracic cancer patients. Caitlin has contributed to a variety of guidelines, policy, and publications, as well as presented to a wide range of audience, at a local, national and international level.

Email: Caitlin.broderick@health.wa.gov.au

Liz is a Consultant Nurse at the University Hospitals of Leicester and Head of Services for Mesothelioma UK.

Liz’s interests within thoracic oncology have always focused on developing the nursing contribution, within the multidisciplinary team, to improve outcomes but also the patient and carer experience across the whole cancer pathway.

Clinically Liz is a core member of the Leicester Thoracic Oncology Multi-disciplinary Team who provide a comprehensive mesothelioma management service to over 250 patients per year. Liz focuses particularly on mesothelioma disease surveillance in both oncology and surgical clinics.

To meet demand locally and nationally Liz developed an interest in Mesothelioma which resulted in her being the founder of Mesothelioma UK. This national charity hosted by the University Hospitals of Leicester has established itself as an essential part of the UK Mesothelioma landscape as a centre of excellence providing specialist information, support and education.  The Charity has an annual income of over £1m which it uses to fund: – 18 Clinical Nurse Specialist in NHS hospitals around the UK, comprehensive national audit, research grants and provide an extensive range of information, support and education resources.

Liz is an Honorary Senior Lecturer at the DeMontfort University, Leicester and Associate Lecturer at the Royal Marsden School of Cancer Nursing and Rehabilitation.

Liz has served 10 years as a committee member (2 years as chair) for the National Lung Cancer Forum for Nurses, 14 years on the British Thoracic Oncology Group steering committee, is a current member of the International Association for the Study of Lung Cancer Membership Committee and Nurses and Allied Professionals Committee. Liz is also proud to be a founding member of the International Thoracic Oncology Nursing Forum.

Liz has individually, and joint authored a number of publications about lung cancer and mesothelioma and gives up to 25 lectures a year at regional, national and international meetings.

John McPhelim is the lead nurse for lung cancer services in NHS Lanarkshire.

He took on this role in July 2005. Prior to this, he worked for 13 years at Stobhill Hospital in Glasgow, as a lung cancer specialist nurse. He is formerly the lead nurse for the West of Scotland Managed Clinical Network for Lung Cancer, and has contributed to several national working groups over the years. He is a past Chair of the National Lung Cancer Forum for Nurses (UK), and currently chairs the Scottish Lung Cancer Nurses Forum.
In January 2013, he was appointed to the position of lead Clinician for The West of Scotland Lung Cancer Managed Clinical Network, the first nurse to hold such a role in Scotland.
His clinical interests focus on supporting patients who are receiving active treatment, and the development of lung cancer services. These include the management of patients receiving various oral therapies and nursing role development in this area. Additionally he has an active interest in the strategic development of lung cancer services and nursing positions. He has published papers on various topics including nursing role development, nurse management of oral therapies, and various other clinical topics, including patient reported outcomes.
Away from work John, enjoys participating in different sports including, running, squash and hill walking. He has been a supporter of Glasgow Celtic for many years, which has been a source of pleasure and misery in equal parts.

Beth Eaby-Sandy is a nurse practitioner at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia in the United States of America. She has been an oncology nurse for 20 years and working specifically with lung cancer patients for the past 15 years. Beth currently serves in various editorial roles for nursing and oncology journals as well as book chapters and other continuing education projects. Beth speaks at, and chairs numerous conferences for oncology nurses and specialize in the supportive care of lung cancer patients. She is passionate about lung cancer and committed to supporting her lung cancer patients in their journey in any way that she can.

Dr. Marianne Davies is a graduate of Yale University School of Nursing (MSN-Oncology Clinical Nurse Specialist and Post-Masters-Acute Care Nurse Practitioner) and MGH Institute of Health Professions (DNP & Certificate of Teaching and Learning). She is an Assistant Professor of Nursing at the Yale School of Nursing, teaching in the Masters and Doctoral programs and coordinator of the Oncology Nurse Practitioner Concentration.  She has a joint appointment at the Yale Comprehensive Cancer Centre.  She has been an Oncology Nurse Practitioner in Thoracic Medical Oncology for several years.  Her area of specialization is on clinical trials of immunotherapy agents, targeted therapies and new drug development. Her specific concentration is the management of toxicities associated with immune and targeted therapeutics. She is a member of the Advanced Practitioner Society for Haematology and Oncology (APSHO), Oncology Nursing Society (ONS), International Association for the Study of Lung Cancer (IASLC), International Thoracic Oncology Nursing Forum (ITONF), Society for Immunotherapy of Cancer (SITC) and Association of Community Care Centres Institute for Clinical Immuno-Oncology (ICLIO).  She serves on the Immunotherapy Guideline Development Boards of the Society of Immunotherapy of Cancer and the National Comprehensive Cancer Network.  She has published and presented extensively on the topics of lung cancer, immunotherapy, targeted therapy and symptom management.

Massey is a certified oncology nurse from CANO and ONS, working as a clinical nurse specialist at William Osler Health System in Brampton, Ontario. She previously worked for over 10 years at Princess Margaret Cancer Center in Toronto, leading lung cancer clinical trials for Dr. Frances Shepherd.  Currently she leads an Immuno-oncology clinic where she sees all the lung cancer patients starting on immunotherapy (either standard of care or on clinical trials).  Part of this activity involves standardization of a teaching class, biomedical monitoring prior to and on immunotherapy and managing the IrAE’s. (Immune-related Adverse Events). Massey is active nationally in more than 3 provinces and 12 cities in Canada, attending all oncology nursing rounds and events to give talks on immunotherapy.

Massey is a joint clinical appointee at the Lawrence S. Bloomberg Faculty of nursing at University of Toronto, Canada. Her area of interest is patient and family education, and improve the patient’s experience and outcome.

Recognized for her outstanding achievements by CANO, CCO (Cancer Care Ontario) and ONS, Massey lectures nationally and internationally on lung cancer, immunotherapy and cancer patient education.

Mary Duffy, RGN/RSCN, RSM, Graduate Diploma of Advanced Nursing in Oncology and Palliative care. M. Phil by Nursing Research.

Mary Duffy is the Advanced Practice, Nurse Consultant for the Lung Cancer Service and Cancer Unknown Primary (CUP) Service  at the Peter Mac Callum Cancer Centre, Melbourne Australia and works primarily with patients who have lung cancer or mesothelioma, and their families.

Mary has worked with lung cancer patients for over 20 years in a variety of roles. Her areas of interest include all aspects of supportive care for people with lung cancer, mesothelioma and CUP  including, symptom management, patient and carer information and support. Mary advocates for palliative care for the patient groups she cares for and has a close working relationship with the palliative teams in the hospital and local communities.

Mary is an active member of both, national and international, nursing and lung cancer professional organisations and is the inaugural chairperson of the Australia and New Zealand Lung Cancer Nurses Forum (ANZ-LCNF).

She has presented at both national and international conferences.

Following a career in thoracic medicine, Vanessa joined the Lung Cancer Team at Aintree University Hospital, Liverpool in 1999 as a Clinical Nurse Specialist. Vanessa’s interests in lung cancer and mesothelioma include improving the patient and carer experience throughout the pathway. She is interested in the development of nurse led services and pre –post habitation. She has given invited presentations on both national and international level, on various aspects of lung cancer including: Wellbeing; Holistic Needs and Surgical Pathway & Navigating pathways. She is a past member of BTOG steering group, and former chair of the Thoracic Surgical Group chair.  Vanessa is currently member of the IASLC subcommittee for Nurses and AHP’s. She is delighted to be a member of the National Lung Cancer Forum (NLCFN) for Nurses, currently  chairperson for the NLCFN